{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:48:04Z","timestamp":1780638484590,"version":"3.54.1"},"reference-count":107,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-026-11532-3","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T07:46:17Z","timestamp":1775029577000},"page":"2905-2935","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Rapid screening of potent and mechanistically insightful repurposable anticancer drugs targeting EGFR for non-small cell lung cancer: machine learning-aided and structure-guided approach"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-9819-8591","authenticated-orcid":false,"given":"Md. Shakil","family":"Ahamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3923-1266","authenticated-orcid":false,"given":"Sheikh Abdullah","family":"Al Ashik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"key":"11532_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"11532_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN et al (2025) Cancer statistics, 2025. CA Cancer J Clin 75:10\u201345. https:\/\/doi.org\/10.3322\/caac.21871","journal-title":"CA Cancer J Clin"},{"key":"11532_CR3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032899","volume":"102","author":"Y Alduais","year":"2023","unstructured":"Alduais Y, Zhang H, Fan F et al (2023) Non-small cell lung cancer (NSCLC): a review of risk factors, diagnosis, and treatment. Medicine 102:e32899. https:\/\/doi.org\/10.1097\/MD.0000000000032899","journal-title":"Medicine"},{"key":"11532_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17050864","volume":"17","author":"J Jovi\u010di\u0107-Bata","year":"2025","unstructured":"Jovi\u010di\u0107-Bata J, Sazdani\u0107-Veliki\u0107 D, \u0160evo M et al (2025) Lifestyle, environmental, occupational, and dietary risk factors in small-cell vs. non-small-cell advanced lung cancer patients: is there a connection? Cancers 17:864. https:\/\/doi.org\/10.3390\/cancers17050864","journal-title":"Cancers"},{"key":"11532_CR5","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1016\/j.ejca.2012.03.007","volume":"48","author":"S Couraud","year":"2012","unstructured":"Couraud S, Zalcman G, Milleron B et al (2012) Lung cancer in never smokers\u2014a review. Eur J Cancer 48:1299\u20131311. https:\/\/doi.org\/10.1016\/j.ejca.2012.03.007","journal-title":"Eur J Cancer"},{"key":"11532_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-023-00523-5","volume":"9","author":"X Bai","year":"2023","unstructured":"Bai X, Sun P, Wang X et al (2023) Structure and dynamics of the EGFR\/HER2 heterodimer. Cell Discov 9:18. https:\/\/doi.org\/10.1038\/s41421-023-00523-5","journal-title":"Cell Discov"},{"key":"11532_CR7","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","volume":"15","author":"DE Johnson","year":"2018","unstructured":"Johnson DE, O\u2019Keefe RA, Grandis JR (2018) Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer. Nat Rev Clin Oncol 15:234\u2013248. https:\/\/doi.org\/10.1038\/nrclinonc.2018.8","journal-title":"Nat Rev Clin Oncol"},{"key":"11532_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/sj.leu.2402460","volume":"16","author":"J Lee Jr","year":"2002","unstructured":"Lee J Jr, McCubrey J (2002) The Raf\/MEK\/ERK signal transduction cascade as a target for chemotherapeutic intervention in leukemia. Leukemia 16:486\u2013507. https:\/\/doi.org\/10.1038\/sj.leu.2402460","journal-title":"Leukemia"},{"key":"11532_CR9","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/cbin.11209","volume":"44","author":"T Shen","year":"2020","unstructured":"Shen T, Guo Q (2020) EGFR signaling pathway occupies an important position in cancer-related downstream signaling pathways of Pyk2. Cell Biol Int 44:2\u201313. https:\/\/doi.org\/10.1002\/cbin.11209","journal-title":"Cell Biol Int"},{"key":"11532_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01899-w","volume":"9","author":"C Tomuleasa","year":"2024","unstructured":"Tomuleasa C, Tigu A-B, Munteanu R et al (2024) Therapeutic advances of targeting receptor tyrosine kinases in cancer. Signal Transduct Target Ther 9:201. https:\/\/doi.org\/10.1038\/s41392-024-01899-w","journal-title":"Signal Transduct Target Ther"},{"key":"11532_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.00942","volume":"10","author":"Y Yu","year":"2020","unstructured":"Yu Y, Gong L, Ye J (2020) The role of aberrant metabolism in cancer: insights into the interplay between cell metabolic reprogramming, metabolic syndrome, and cancer. Front Oncol 10:942. https:\/\/doi.org\/10.3389\/fonc.2020.00942","journal-title":"Front Oncol"},{"key":"11532_CR12","first-page":"411","volume":"4","author":"Y Lin","year":"2014","unstructured":"Lin Y, Wang X, Jin H (2014) EGFR-TKI resistance in NSCLC patients: mechanisms and strategies. Am J Cancer Res 4:411\u2013435","journal-title":"Am J Cancer Res"},{"key":"11532_CR13","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s43018-021-00195-8","volume":"2","author":"A Passaro","year":"2021","unstructured":"Passaro A, J\u00e4nne PA, Mok T, Peters S (2021) Overcoming therapy resistance in EGFR-mutant lung cancer. Nat Cancer 2:377\u2013391. https:\/\/doi.org\/10.1038\/s43018-021-00195-8","journal-title":"Nat Cancer"},{"key":"11532_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0099-9","volume":"4","author":"M Yuan","year":"2019","unstructured":"Yuan M, Huang L-L, Chen J-H et al (2019) The emerging treatment landscape of targeted therapy in non-small-cell lung cancer. Signal Transduct Target Ther 4:1\u201314. https:\/\/doi.org\/10.1038\/s41392-019-0099-9","journal-title":"Signal Transduct Target Ther"},{"key":"11532_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0202-2","volume":"51","author":"HK Byeon","year":"2019","unstructured":"Byeon HK, Ku M, Yang J (2019) Beyond EGFR inhibition: multilateral combat strategies to stop the progression of head and neck cancer. Exp Mol Med 51:1\u201314. https:\/\/doi.org\/10.1038\/s12276-018-0202-2","journal-title":"Exp Mol Med"},{"key":"11532_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18:41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"key":"11532_CR17","doi-asserted-by":"publisher","DOI":"10.23917\/pharmacon.v22i2.13698","author":"KMT Islam","year":"2025","unstructured":"Islam KMT (2025) Drug repurposing in modern drug discovery: role of in silico study. Pharmacon J Farm Indones. https:\/\/doi.org\/10.23917\/pharmacon.v22i2.13698","journal-title":"Pharmacon J Farm Indones"},{"key":"11532_CR18","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.drudis.2022.03.006","volume":"27","author":"C Choudhury","year":"2022","unstructured":"Choudhury C, Arul Murugan N, Priyakumar UD (2022) Structure-based drug repurposing: traditional and advanced AI\/ML-aided methods. Drug Discov Today 27:1847\u20131861. https:\/\/doi.org\/10.1016\/j.drudis.2022.03.006","journal-title":"Drug Discov Today"},{"key":"11532_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1080\/17460441.2021.1883585","volume":"16","author":"Z Tanoli","year":"2021","unstructured":"Tanoli Z, V\u00e4h\u00e4-Koskela M, Aittokallio T (2021) Artificial intelligence, machine learning, and drug repurposing in cancer. Expert Opin Drug Discov 16:977\u2013989. https:\/\/doi.org\/10.1080\/17460441.2021.1883585","journal-title":"Expert Opin Drug Discov"},{"key":"11532_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.146985","volume":"325","author":"KMT Islam","year":"2025","unstructured":"Islam KMT, Shibly AZ (2025) Network and pharmacophore guided and BCL2 and HSP90AA1 targeted drug repurposable approaches against rheumatoid arthritis mediated diffuse large B-cell lymphoma. Int J Biol Macromol 325:146985. https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.146985","journal-title":"Int J Biol Macromol"},{"key":"11532_CR21","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.intonc.2024.10.001","volume":"1","author":"H Zhang","year":"2025","unstructured":"Zhang H, Tong HHY (2025) Discovery of novel EGFR and BRAF inhibitors by machine learning approach. Intell Oncol 1:7\u201316. https:\/\/doi.org\/10.1016\/j.intonc.2024.10.001","journal-title":"Intell Oncol"},{"key":"11532_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-024-01954-7","volume":"22","author":"R Zhou","year":"2024","unstructured":"Zhou R, Liu Z, Wu T et al (2024) Machine learning-aided discovery of T790M-mutant EGFR inhibitor CDDO-Me effectively suppresses non-small cell lung cancer growth. Cell Commun Signal 22:585. https:\/\/doi.org\/10.1186\/s12964-024-01954-7","journal-title":"Cell Commun Signal"},{"key":"11532_CR23","doi-asserted-by":"publisher","first-page":"8332","DOI":"10.1007\/s12010-024-04958-8","volume":"196","author":"MH Ibraheim","year":"2024","unstructured":"Ibraheim MH, Maher I, Khater I (2024) In silico repurposing of a novel inhibitor (drug) of EGFR and VEGFR-2 kinases of cancer by pharmacokinetics, toxicity, molecular docking, and molecular dynamics simulation. Appl Biochem Biotechnol 196:8332\u20138365. https:\/\/doi.org\/10.1007\/s12010-024-04958-8","journal-title":"Appl Biochem Biotechnol"},{"key":"11532_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0321500","volume":"20","author":"MN Khan","year":"2025","unstructured":"Khan MN, Farooq U, Khushal A et al (2025) Unraveling potential EGFR kinase inhibitors: computational screening, molecular dynamics insights, and MMPBSA analysis for targeted cancer therapy development. PLoS ONE 20:e0321500. https:\/\/doi.org\/10.1371\/journal.pone.0321500","journal-title":"PLoS ONE"},{"key":"11532_CR25","doi-asserted-by":"publisher","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","volume":"40","author":"A Gaulton","year":"2012","unstructured":"Gaulton A, Bellis LJ, Bento AP et al (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100\u2013D1107. https:\/\/doi.org\/10.1093\/nar\/gkr777","journal-title":"Nucleic Acids Res"},{"key":"11532_CR26","doi-asserted-by":"publisher","DOI":"10.1515\/comp-2022-0278","author":"A Amato","year":"2023","unstructured":"Amato A, Lecce VD (2023) Data preprocessing impact on machine learning algorithm performance. Open Comput Sci. https:\/\/doi.org\/10.1515\/comp-2022-0278","journal-title":"Open Comput Sci"},{"key":"11532_CR27","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, et al (2011) Scikit-learn: machine learning in Python. J Mach Learn Res"},{"key":"11532_CR28","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1109\/TKDE.2019.2912815","volume":"32","author":"T-T Wong","year":"2020","unstructured":"Wong T-T, Yeh P-Y (2020) Reliable accuracy estimates from k-fold cross validation. IEEE Trans Knowl Data Eng 32:1586\u20131594. https:\/\/doi.org\/10.1109\/TKDE.2019.2912815","journal-title":"IEEE Trans Knowl Data Eng"},{"key":"11532_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1080\/10485252.2017.1404598","volume":"30","author":"Y Jung","year":"2018","unstructured":"Jung Y (2018) Multiple predicting K-fold cross-validation for model selection. J Nonparametr Stat 30:197\u2013215. https:\/\/doi.org\/10.1080\/10485252.2017.1404598","journal-title":"J Nonparametr Stat"},{"key":"11532_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-020-00456-1","volume":"12","author":"AP Bento","year":"2020","unstructured":"Bento AP, Hersey A, F\u00e9lix E et al (2020) An open source chemical structure curation pipeline using RDKit. J Cheminform 12:51. https:\/\/doi.org\/10.1186\/s13321-020-00456-1","journal-title":"J Cheminform"},{"key":"11532_CR31","doi-asserted-by":"publisher","first-page":"5363","DOI":"10.1021\/acs.jpcb.4c01875","volume":"128","author":"H Zhou","year":"2024","unstructured":"Zhou H, Skolnick J (2024) Utility of the Morgan fingerprint in structure-based virtual ligand screening. J Phys Chem B 128:5363\u20135370. https:\/\/doi.org\/10.1021\/acs.jpcb.4c01875","journal-title":"J Phys Chem B"},{"key":"11532_CR32","doi-asserted-by":"publisher","first-page":"10971","DOI":"10.1038\/s41598-024-73867-x","volume":"15","author":"G Narasimhan","year":"2025","unstructured":"Narasimhan G, Victor A (2025) A hybrid approach with metaheuristic optimization and random forest in improving heart disease prediction. Sci Rep 15:10971. https:\/\/doi.org\/10.1038\/s41598-024-73867-x","journal-title":"Sci Rep"},{"key":"11532_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-018-0449-9","volume":"17","author":"R Koprowski","year":"2018","unstructured":"Koprowski R, Foster KR (2018) Machine learning and medicine: book review and commentary. Biomed Eng Online 17:17. https:\/\/doi.org\/10.1186\/s12938-018-0449-9","journal-title":"Biomed Eng Online"},{"key":"11532_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.627574","author":"P Pantziarka","year":"2021","unstructured":"Pantziarka P, Capistrano IR, De Potter A et al (2021) An open access database of licensed cancer drugs. Front Pharmacol. https:\/\/doi.org\/10.3389\/fphar.2021.627574","journal-title":"Front Pharmacol"},{"key":"11532_CR35","doi-asserted-by":"publisher","first-page":"D1516","DOI":"10.1093\/nar\/gkae1059","volume":"53","author":"S Kim","year":"2025","unstructured":"Kim S, Chen J, Cheng T et al (2025) PubChem 2025 update. Nucleic Acids Res 53:D1516\u2013D1525. https:\/\/doi.org\/10.1093\/nar\/gkae1059","journal-title":"Nucleic Acids Res"},{"key":"11532_CR36","unstructured":"LigPrep, Version 2024\u20132, Schr\u00f6dinger, LLC, New York, NY, USA, 2024"},{"key":"11532_CR37","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","volume":"19","author":"RC Johnston","year":"2023","unstructured":"Johnston RC, Yao K, Kaplan Z et al (2023) Epik: p Ka and protonation state prediction through machine learning. J Chem Theory Comput 19:2380\u20132388. https:\/\/doi.org\/10.1021\/acs.jctc.3c00044","journal-title":"J Chem Theory Comput"},{"key":"11532_CR38","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10792-024-03157-y","volume":"44","author":"K Serefoglu Cabuk","year":"2024","unstructured":"Serefoglu Cabuk K, Cengiz SK, Guler MG et al (2024) Chasing the objective upper eyelid symmetry formula; R2, RMSE, POC, MAE, and MSE. Int Ophthalmol 44:303. https:\/\/doi.org\/10.1007\/s10792-024-03157-y","journal-title":"Int Ophthalmol"},{"key":"11532_CR39","doi-asserted-by":"publisher","DOI":"10.7717\/peerj-cs.623","volume":"7","author":"D Chicco","year":"2021","unstructured":"Chicco D, Warrens MJ, Jurman G (2021) The coefficient of determination R-squared is more informative than SMAPE, MAE, MAPE, MSE and RMSE in regression analysis evaluation. PeerJ Comput Sci 7:e623. https:\/\/doi.org\/10.7717\/peerj-cs.623","journal-title":"PeerJ Comput Sci"},{"key":"11532_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM (2000) The protein data bank. Nucleic Acids Res 28:235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"key":"11532_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T et al (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"11532_CR42","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson MHM, S\u00f8ndergaard CR, Rostkowski M, Jensen JH (2011) PROPKA3: consistent treatment of internal and surface residues in empirical p Ka predictions. J Chem Theory Comput 7:525\u2013537. https:\/\/doi.org\/10.1021\/ct100578z","journal-title":"J Chem Theory Comput"},{"key":"11532_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.142009","volume":"1336","author":"BK Chagaleti","year":"2025","unstructured":"Chagaleti BK, Saravanan V, Oubella A et al (2025) Pyrazolopyrimidine fused thiazolidinone hybrids as CDK2 inhibitors: insights from pharmacophore modeling, docking, DFT and molecular dynamics simulations. J Mol Struct 1336:142009. https:\/\/doi.org\/10.1016\/j.molstruc.2025.142009","journal-title":"J Mol Struct"},{"key":"11532_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2025.100616","volume":"23","author":"KMT Islam","year":"2025","unstructured":"Islam KMT, Khanam R, Roy A et al (2025) Transcriptomics analysis unveils the complex interplay between diabetes and hypertension in regulating renal cell carcinoma pathway followed by pancreatic metastasis. J Genet Eng Biotechnol 23:100616. https:\/\/doi.org\/10.1016\/j.jgeb.2025.100616","journal-title":"J Genet Eng Biotechnol"},{"key":"11532_CR45","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1021\/jm0306430","volume":"47","author":"RA Friesner","year":"2004","unstructured":"Friesner RA, Banks JL, Murphy RB et al (2004) Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 47:1739\u20131749. https:\/\/doi.org\/10.1021\/jm0306430","journal-title":"J Med Chem"},{"key":"11532_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgeb.2025.100654","volume":"24","author":"KM Tanjida Islam","year":"2026","unstructured":"Tanjida Islam KM, Khanam R, Mahmud S (2026) Computational discovery of marine natural phytochemicals as novel SIRT7 inhibitors for cancer treatment. J Genet Eng Biotechnol 24:100654. https:\/\/doi.org\/10.1016\/j.jgeb.2025.100654","journal-title":"J Genet Eng Biotechnol"},{"key":"11532_CR47","doi-asserted-by":"publisher","DOI":"10.36877\/pddbs.a0000424","author":"PF Ayodele","year":"2023","unstructured":"Ayodele PF, Bamigbade A, Bamigbade OO et al (2023) Illustrated procedure to perform molecular docking using PyRx and biovia discovery studio visualizer: a case study of 10kt with atropine. Prog Drug Discov Biomed Sci. https:\/\/doi.org\/10.36877\/pddbs.a0000424","journal-title":"Prog Drug Discov Biomed Sci"},{"key":"11532_CR48","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1021\/ci200227u","volume":"51","author":"RA Laskowski","year":"2011","unstructured":"Laskowski RA, Swindells MB (2011) LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model 51:2778\u20132786. https:\/\/doi.org\/10.1021\/ci200227u","journal-title":"J Chem Inf Model"},{"key":"11532_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1109\/SC.2006.54","volume-title":"ACM\/IEEE SC 2006 conference (SC\u201906)","author":"KJ Bowers","year":"2006","unstructured":"Bowers KJ, Chow DE, Xu H et al (2006) Scalable algorithms for molecular dynamics simulations on commodity clusters. ACM\/IEEE SC 2006 conference (SC\u201906). IEEE, Tampa, pp 43\u201343"},{"key":"11532_CR50","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD et al (1983) Comparison of simple potential functions for simulating liquid water. J Chem Phys 79:926\u2013935. https:\/\/doi.org\/10.1063\/1.445869","journal-title":"J Chem Phys"},{"key":"11532_CR51","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D et al (2021) OPLS4: improving force field accuracy on challenging regimes of chemical space. J Chem Theory Comput 17:4291\u20134300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302","journal-title":"J Chem Theory Comput"},{"key":"11532_CR52","doi-asserted-by":"publisher","first-page":"W194","DOI":"10.1093\/nar\/gkae415","volume":"52","author":"B Ye","year":"2024","unstructured":"Ye B, Tian W, Wang B, Liang J (2024) CASTpFold: computed atlas of surface topography of the universe of protein folds. Nucleic Acids Res 52:W194\u2013W199. https:\/\/doi.org\/10.1093\/nar\/gkae415","journal-title":"Nucleic Acids Res"},{"key":"11532_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1002\/pro.3923","volume":"30","author":"BJ Grant","year":"2021","unstructured":"Grant BJ, Skj\u00e6rven L, Yao X (2021) The Bio3D packages for structural bioinformatics. Protein Sci 30:20\u201330. https:\/\/doi.org\/10.1002\/pro.3923","journal-title":"Protein Sci"},{"key":"11532_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jmgm.2013.09.005","volume":"46","author":"C Mulakala","year":"2013","unstructured":"Mulakala C, Viswanadhan VN (2013) Could MM-GBSA be accurate enough for calculation of absolute protein\/ligand binding free energies? J Mol Graph Model 46:41\u201351. https:\/\/doi.org\/10.1016\/j.jmgm.2013.09.005","journal-title":"J Mol Graph Model"},{"key":"11532_CR55","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li J, Abel R, Zhu K et al (2011) The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling. Proteins 79:2794\u20132812. https:\/\/doi.org\/10.1002\/prot.23106","journal-title":"Proteins"},{"key":"11532_CR56","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1517\/17460441.2011.598924","volume":"6","author":"JG Frey","year":"2011","unstructured":"Frey JG, Bird CL (2011) Web-based services for drug design and discovery. Expert Opin Drug Discov 6:885\u2013895. https:\/\/doi.org\/10.1517\/17460441.2011.598924","journal-title":"Expert Opin Drug Discov"},{"key":"11532_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiolchem.2024.108134","volume":"112","author":"BK Chagaleti","year":"2024","unstructured":"Chagaleti BK, B. SK, G.v. A et al (2024) Targeting cyclin-dependent kinase 2 CDK2: insights from molecular docking and dynamics simulation\u2014a systematic computational approach to discover novel cancer therapeutics. Comput Biol Chem 112:108134. https:\/\/doi.org\/10.1016\/j.compbiolchem.2024.108134","journal-title":"Comput Biol Chem"},{"key":"11532_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-18547-0","volume":"15","author":"KMT Islam","year":"2025","unstructured":"Islam KMT, Islam MM, Habib JB et al (2025) In silico approaches unveil the mechanism of action of Eclipta prostrata against acute myeloid leukemia. Sci Rep 15:33267. https:\/\/doi.org\/10.1038\/s41598-025-18547-0","journal-title":"Sci Rep"},{"key":"11532_CR59","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"DA Filimonov","year":"2014","unstructured":"Filimonov DA, Lagunin AA, Gloriozova TA et al (2014) Prediction of the biological activity spectra of organic compounds using the pass online web resource. Chem Heterocycl Compd 50:444\u2013457. https:\/\/doi.org\/10.1007\/s10593-014-1496-1","journal-title":"Chem Heterocycl Compd"},{"key":"11532_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021689","volume":"24","author":"AA Lagunin","year":"2023","unstructured":"Lagunin AA, Rudik AV, Pogodin PV et al (2023) CLC-Pred 2.0: a freely available web application for in silico prediction of human cell line cytotoxicity and molecular mechanisms of action for druglike compounds. Int J Mol Sci 24:1689. https:\/\/doi.org\/10.3390\/ijms24021689","journal-title":"Int J Mol Sci"},{"key":"11532_CR61","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1080\/02763869.2020.1826228","volume":"39","author":"J White","year":"2020","unstructured":"White J (2020) PubMed 2.0. Med Ref Serv Q 39:382\u2013387. https:\/\/doi.org\/10.1080\/02763869.2020.1826228","journal-title":"Med Ref Serv Q"},{"key":"11532_CR62","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.joi.2017.06.005","volume":"11","author":"G Halevi","year":"2017","unstructured":"Halevi G, Moed H, Bar-Ilan J (2017) Suitability of Google Scholar as a source of scientific information and as a source of data for scientific evaluation\u2014review of the literature. J Informetr 11:823\u2013834. https:\/\/doi.org\/10.1016\/j.joi.2017.06.005","journal-title":"J Informetr"},{"key":"11532_CR63","doi-asserted-by":"publisher","first-page":"38789","DOI":"10.18632\/oncotarget.5887","volume":"6","author":"T Hirano","year":"2015","unstructured":"Hirano T, Yasuda H, Tani T et al (2015) In vitro modeling to determine mutation specificity of EGFR tyrosine kinase inhibitors against clinically relevant EGFR mutants in non-small-cell lung cancer. Oncotarget 6:38789\u201338803. https:\/\/doi.org\/10.18632\/oncotarget.5887","journal-title":"Oncotarget"},{"key":"11532_CR64","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1038\/s43018-024-00781-6","volume":"5","author":"CE Whitehead","year":"2024","unstructured":"Whitehead CE, Ziemke EK, Frankowski-McGregor CL et al (2024) A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistance. Nat Cancer 5:1250\u20131266. https:\/\/doi.org\/10.1038\/s43018-024-00781-6","journal-title":"Nat Cancer"},{"key":"11532_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s13321-019-0362-7","volume":"11","author":"EW Bell","year":"2019","unstructured":"Bell EW, Zhang Y (2019) DockRMSD: an open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism. J Cheminform 11:40. https:\/\/doi.org\/10.1186\/s13321-019-0362-7","journal-title":"J Cheminform"},{"key":"11532_CR66","doi-asserted-by":"publisher","first-page":"40120","DOI":"10.1039\/D1RA06842C","volume":"11","author":"R Alam","year":"2021","unstructured":"Alam R, Imon RR, Talukder MEK et al (2021) GC-MS analysis of phytoconstituents from Ruellia prostrata and Senna tora and identification of potential anti-viral activity against SARS-CoV-2. RSC Adv 11:40120\u201340135. https:\/\/doi.org\/10.1039\/D1RA06842C","journal-title":"RSC Adv"},{"key":"11532_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-97","volume":"11","author":"A Pandini","year":"2010","unstructured":"Pandini A, Fornili A, Kleinjung J (2010) Structural alphabets derived from attractors in conformational space. BMC Bioinformatics 11:97. https:\/\/doi.org\/10.1186\/1471-2105-11-97","journal-title":"BMC Bioinformatics"},{"key":"11532_CR68","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MYu Lobanov","year":"2008","unstructured":"Lobanov MYu, Bogatyreva NS, Galzitskaya OV (2008) Radius of gyration as an indicator of protein structure compactness. Mol Biol 42:623\u2013628. https:\/\/doi.org\/10.1134\/S0026893308040195","journal-title":"Mol Biol"},{"key":"11532_CR69","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/0022-2836(84)90231-6","volume":"178","author":"TJ Richmond","year":"1984","unstructured":"Richmond TJ (1984) Solvent accessible surface area and excluded volume in proteins: analytical equations for overlapping spheres and implications for the hydrophobic effect. J Mol Biol 178:63\u201389. https:\/\/doi.org\/10.1016\/0022-2836(84)90231-6","journal-title":"J Mol Biol"},{"key":"11532_CR70","doi-asserted-by":"publisher","first-page":"6524","DOI":"10.1080\/07391102.2020.1801507","volume":"39","author":"P Sharma","year":"2021","unstructured":"Sharma P, Joshi T, Joshi T et al (2021) Molecular dynamics simulation for screening phytochemicals as \u03b1-amylase inhibitors from medicinal plants. J Biomol Struct Dyn 39:6524\u20136538. https:\/\/doi.org\/10.1080\/07391102.2020.1801507","journal-title":"J Biomol Struct Dyn"},{"key":"11532_CR71","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1002\/pro.2449","volume":"23","author":"CN Pace","year":"2014","unstructured":"Pace CN, Fu H, Lee Fryar K et al (2014) Contribution of hydrogen bonds to protein stability. Protein Sci 23:652\u2013661. https:\/\/doi.org\/10.1002\/pro.2449","journal-title":"Protein Sci"},{"key":"11532_CR72","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber DF, Johnson SR, Cheng H-Y et al (2002) Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem 45:2615\u20132623. https:\/\/doi.org\/10.1021\/jm020017n","journal-title":"J Med Chem"},{"key":"11532_CR73","doi-asserted-by":"publisher","first-page":"24891","DOI":"10.1021\/acsomega.1c03736","volume":"6","author":"R Srivastava","year":"2021","unstructured":"Srivastava R (2021) Theoretical studies on the molecular properties, toxicity, and biological efficacy of 21 new chemical entities. ACS Omega 6:24891\u201324901. https:\/\/doi.org\/10.1021\/acsomega.1c03736","journal-title":"ACS Omega"},{"key":"11532_CR74","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1007\/BF02897225","volume":"26","author":"SPC Cole","year":"1990","unstructured":"Cole SPC (1990) Patterns of cross-resistance in a multidrug-resistant small-cell lung carcinoma cell line. Cancer Chemother Pharmacol 26:250\u2013256. https:\/\/doi.org\/10.1007\/BF02897225","journal-title":"Cancer Chemother Pharmacol"},{"key":"11532_CR75","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1038\/sj.bjc.6990133","volume":"79","author":"XF Hu","year":"1999","unstructured":"Hu XF, Slater A, Rischin D et al (1999) Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line. Br J Cancer 79:831\u2013837. https:\/\/doi.org\/10.1038\/sj.bjc.6990133","journal-title":"Br J Cancer"},{"key":"11532_CR76","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/BF01525435","volume":"37","author":"AJ Rowland","year":"1993","unstructured":"Rowland AJ, Pietersz GA, McKenzie IFC (1993) Preclinical investigation of the antitumour effects of anti-CD19-idarubicin immunoconjugates. Cancer Immunol Immunother CII 37:195\u2013202. https:\/\/doi.org\/10.1007\/BF01525435","journal-title":"Cancer Immunol Immunother CII"},{"key":"11532_CR77","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/BF00685850","volume":"36","author":"MJ Kuffel","year":"1995","unstructured":"Kuffel MJ, Ames MM (1995) Comparative resistance of idarubicin, doxorubicin and their C-13 alcohol metabolites in human MDR1 transfected NIH-3T3 cells. Cancer Chemother Pharmacol 36:223\u2013226. https:\/\/doi.org\/10.1007\/BF00685850","journal-title":"Cancer Chemother Pharmacol"},{"key":"11532_CR78","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1179\/joc.2005.17.6.663","volume":"17","author":"P Orlandi","year":"2005","unstructured":"Orlandi P, Barbara C, Bocci G et al (2005) Idarubicin and idarubicinol effects on breast cancer multicellular spheroids. J Chemother 17:663\u2013667. https:\/\/doi.org\/10.1179\/joc.2005.17.6.663","journal-title":"J Chemother"},{"key":"11532_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25061300","volume":"25","author":"S Anuchapreeda","year":"2020","unstructured":"Anuchapreeda S, Chueahongthong F, Viriyaadhammaa N et al (2020) Antileukemic cell proliferation of active compounds from Kaffir Lime (Citrus hystrix) leaves. Molecules 25:1300. https:\/\/doi.org\/10.3390\/molecules25061300","journal-title":"Molecules"},{"key":"11532_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/genes15050648","volume":"15","author":"I Krastinaite","year":"2024","unstructured":"Krastinaite I, Charkavliuk S, Navakauskiene R, Borutinskaite VV (2024) Metformin as an enhancer for the treatment of chemoresistant CD34+ acute myeloid leukemia cells. Genes 15:648. https:\/\/doi.org\/10.3390\/genes15050648","journal-title":"Genes"},{"issue":"4","key":"11532_CR81","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/10428190801935752","volume":"49","author":"DJ Adams","year":"2008","unstructured":"Adams DJ, Sandvold ML, Myhren F et al (2008) Anti proliferative activity of ELACYT\u2122 (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells. Leuk Lymphoma 49(4):786\u2013797. https:\/\/doi.org\/10.1080\/10428190801935752","journal-title":"Leuk Lymphoma"},{"key":"11532_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094931","volume":"22","author":"JJ Lica","year":"2021","unstructured":"Lica JJ, Wiecz\u00f3r M, Grabe GJ et al (2021) Effective drug concentration and selectivity depends on fraction of primitive cells. Int J Mol Sci 22:4931. https:\/\/doi.org\/10.3390\/ijms22094931","journal-title":"Int J Mol Sci"},{"key":"11532_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123145","volume":"15","author":"G Rodr\u00edguez-Mac\u00edas","year":"2023","unstructured":"Rodr\u00edguez-Mac\u00edas G, Briz O, Cives-Losada C et al (2023) Role of intracellular drug disposition in the response of acute myeloid leukemia to cytarabine and idarubicin induction chemotherapy. Cancers 15:3145. https:\/\/doi.org\/10.3390\/cancers15123145","journal-title":"Cancers"},{"key":"11532_CR84","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3324\/haematol.2018.214882","volume":"105","author":"H Kuusanm\u00e4ki","year":"2020","unstructured":"Kuusanm\u00e4ki H, Lepp\u00e4 A-M, P\u00f6l\u00f6nen P et al (2020) Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia. Haematologica 105:708\u2013720. https:\/\/doi.org\/10.3324\/haematol.2018.214882","journal-title":"Haematologica"},{"key":"11532_CR85","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1158\/2159-8290.CD-17-0507","volume":"7","author":"A Drilon","year":"2017","unstructured":"Drilon A, Nagasubramanian R, Blake JF et al (2017) A next-generation TRK kinase inhibitor overcomes acquired resistance to prior TRK kinase inhibition in patients with TRK fusion\u2013positive solid tumors. Cancer Discov 7:963\u2013972. https:\/\/doi.org\/10.1158\/2159-8290.CD-17-0507","journal-title":"Cancer Discov"},{"key":"11532_CR86","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.annonc.2020.08.2232","volume":"31","author":"GD Demetri","year":"2020","unstructured":"Demetri GD, Antonescu CR, Bjerkehagen B et al (2020) Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network. Ann Oncol 31:1506\u20131517. https:\/\/doi.org\/10.1016\/j.annonc.2020.08.2232","journal-title":"Ann Oncol"},{"key":"11532_CR87","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41416-024-02760-1","volume":"131","author":"P Roa","year":"2024","unstructured":"Roa P, Foglizzo V, Harada G et al (2024) Zurletrectinib is a next-generation TRK inhibitor with strong intracranial activity against NTRK fusion-positive tumours with on-target resistance to first-generation agents. Br J Cancer 131:601\u2013610. https:\/\/doi.org\/10.1038\/s41416-024-02760-1","journal-title":"Br J Cancer"},{"key":"11532_CR88","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1080\/17512433.2019.1661775","volume":"12","author":"N Federman","year":"2019","unstructured":"Federman N, McDermott R (2019) Larotrectinib, a highly selective tropomyosin receptor kinase (TRK) inhibitor for the treatment of TRK fusion cancer. Expert Rev Clin Pharmacol 12:931\u2013939. https:\/\/doi.org\/10.1080\/17512433.2019.1661775","journal-title":"Expert Rev Clin Pharmacol"},{"key":"11532_CR89","doi-asserted-by":"publisher","first-page":"5539","DOI":"10.1111\/jcmm.17530","volume":"26","author":"W Kong","year":"2022","unstructured":"Kong W, Zhu H, Zheng S et al (2022) Larotrectinib induces autophagic cell death through AMPK\/mTOR signalling in colon cancer. J Cell Mol Med 26:5539\u20135550. https:\/\/doi.org\/10.1111\/jcmm.17530","journal-title":"J Cell Mol Med"},{"key":"11532_CR90","doi-asserted-by":"publisher","first-page":"4998","DOI":"10.1021\/jm200216q","volume":"54","author":"K Miwa","year":"2011","unstructured":"Miwa K, Hitaka T, Imada T et al (2011) Discovery of 1-{4-[1-(2,6-Difluorobenzyl)-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3- d ]pyrimidin-6-yl]phenyl}-3-methoxyurea (TAK-385) as a potent, orally active, non-peptide antagonist of the human gonadotropin-releasing hormone receptor. J Med Chem 54:4998\u20135012. https:\/\/doi.org\/10.1021\/jm200216q","journal-title":"J Med Chem"},{"key":"11532_CR91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejphar.2013.12.001","volume":"723","author":"D Nakata","year":"2014","unstructured":"Nakata D, Masaki T, Tanaka A et al (2014) Suppression of the hypothalamic\u2013pituitary\u2013gonadal axis by TAK-385 (relugolix), a novel, investigational, orally active, small molecule gonadotropin-releasing hormone (GnRH) antagonist: studies in human GnRH receptor knock-in mice. Eur J Pharmacol 723:167\u2013174. https:\/\/doi.org\/10.1016\/j.ejphar.2013.12.001","journal-title":"Eur J Pharmacol"},{"key":"11532_CR92","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/1878-0261.12155","volume":"12","author":"S Sigismund","year":"2018","unstructured":"Sigismund S, Avanzato D, Lanzetti L (2018) Emerging functions of the EGFR in cancer. Mol Oncol 12:3\u201320. https:\/\/doi.org\/10.1002\/1878-0261.12155","journal-title":"Mol Oncol"},{"key":"11532_CR93","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s10120-011-0102-9","volume":"15","author":"B Hotz","year":"2012","unstructured":"Hotz B, Keilholz U, Fusi A et al (2012) In vitro and in vivo antitumor activity of cetuximab in human gastric cancer cell lines in relation to epidermal growth factor receptor (EGFR) expression and mutational phenotype. Gastric Cancer 15:252\u2013264. https:\/\/doi.org\/10.1007\/s10120-011-0102-9","journal-title":"Gastric Cancer"},{"key":"11532_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112420","volume":"18","author":"T Yamaoka","year":"2017","unstructured":"Yamaoka T, Ohba M, Ohmori T (2017) Molecular-targeted therapies for epidermal growth factor receptor and its resistance mechanisms. Int J Mol Sci 18:2420. https:\/\/doi.org\/10.3390\/ijms18112420","journal-title":"Int J Mol Sci"},{"key":"11532_CR95","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2020.1166","volume":"323","author":"OJ Wouters","year":"2020","unstructured":"Wouters OJ, McKee M, Luyten J (2020) Estimated research and development investment needed to bring a new medicine to market, 2009\u20132018. JAMA 323:844\u2013853. https:\/\/doi.org\/10.1001\/jama.2020.1166","journal-title":"JAMA"},{"key":"11532_CR96","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of Covid-19\u2014final report. N Engl J Med 383:1813\u20131826. https:\/\/doi.org\/10.1056\/NEJMoa2007764","journal-title":"N Engl J Med"},{"key":"11532_CR97","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s40258-023-00816-6","volume":"21","author":"KH van der Pol","year":"2023","unstructured":"van der Pol KH, Aljofan M, Blin O et al (2023) Drug repurposing of generic drugs: challenges and the potential role for government. Appl Health Econ Health Policy 21:831\u2013840. https:\/\/doi.org\/10.1007\/s40258-023-00816-6","journal-title":"Appl Health Econ Health Policy"},{"key":"11532_CR98","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411325","volume":"12","author":"Z Wan","year":"2025","unstructured":"Wan Z, Sun X, Li Y et al (2025) Applications of artificial intelligence in drug repurposing. Adv Sci 12:2411325. https:\/\/doi.org\/10.1002\/advs.202411325","journal-title":"Adv Sci"},{"key":"11532_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109754","volume":"187","author":"KMT Islam","year":"2025","unstructured":"Islam KMT, Mahmud S (2025) In-silico exploring pathway and mechanism-based therapeutics for allergic rhinitis: network pharmacology, molecular docking, ADMET, quantum chemistry and machine learning based QSAR approaches. Comput Biol Med 187:109754. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.109754","journal-title":"Comput Biol Med"},{"key":"11532_CR100","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110441","volume":"193","author":"MS Ahamed","year":"2025","unstructured":"Ahamed MS, Al Ashik SA (2025) Computer-aided unveiling molecular mechanisms of Xylocarpus granatum against colorectal cancer: therapeutic intervention targeting P13K-AKT signaling pathway. Comput Biol Med 193:110441. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110441","journal-title":"Comput Biol Med"},{"key":"11532_CR101","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/978-3-030-94651-7_7","volume-title":"Transdisciplinarity","author":"MS Badar","year":"2022","unstructured":"Badar MS, Shamsi S, Ahmed J, Alam MdA (2022) Molecular dynamics simulations: concept, methods, and applications. In: Rezaei N (ed) Transdisciplinarity. Springer International Publishing, Cham, pp 131\u2013151"},{"key":"11532_CR102","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/978-981-15-5530-5_9","volume-title":"Frontiers in protein structure, function, and dynamics","author":"S Singh","year":"2020","unstructured":"Singh S, Singh VK (2020) Molecular dynamics simulation: methods and application. In: Singh DB, Tripathi T (eds) Frontiers in protein structure, function, and dynamics. Springer, Singapore, pp 213\u2013238"},{"key":"11532_CR103","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.copbio.2007.10.005","volume":"18","author":"M-Q Zhang","year":"2007","unstructured":"Zhang M-Q, Wilkinson B (2007) Drug discovery beyond the \u2018rule-of-five.\u2019 Curr Opin Biotechnol 18:478\u2013488. https:\/\/doi.org\/10.1016\/j.copbio.2007.10.005","journal-title":"Curr Opin Biotechnol"},{"key":"11532_CR104","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","volume":"21","author":"BC Doak","year":"2014","unstructured":"Doak BC, Over B, Giordanetto F, Kihlberg J (2014) Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem Biol 21:1115\u20131142. https:\/\/doi.org\/10.1016\/j.chembiol.2014.08.013","journal-title":"Chem Biol"},{"key":"11532_CR105","doi-asserted-by":"publisher","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","volume":"45","author":"M Kanehisa","year":"2017","unstructured":"Kanehisa M, Furumichi M, Tanabe M et al (2017) KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res 45:D353\u2013D361. https:\/\/doi.org\/10.1093\/nar\/gkw1092","journal-title":"Nucleic Acids Res"},{"key":"11532_CR106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25053066","volume":"25","author":"B Abrahams","year":"2024","unstructured":"Abrahams B, Gerber A, Hiss DC (2024) Combination treatment with EGFR inhibitor and doxorubicin synergistically inhibits proliferation of MCF-7 cells and MDA-MB-231 triple-negative breast cancer cells in vitro. Int J Mol Sci 25:3066. https:\/\/doi.org\/10.3390\/ijms25053066","journal-title":"Int J Mol Sci"},{"key":"11532_CR107","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ijbiomac.2017.05.035","volume":"103","author":"M Mehrabi","year":"2017","unstructured":"Mehrabi M, Mansouri K, Soleymani B et al (2017) Development of a human epidermal growth factor derivative with EGFR-blocking and depleted biological activities: a comparative in vitro study using EGFR-positive breast cancer cells. Int J Biol Macromol 103:275\u2013285. https:\/\/doi.org\/10.1016\/j.ijbiomac.2017.05.035","journal-title":"Int J Biol Macromol"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11532-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-026-11532-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-026-11532-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T12:10:10Z","timestamp":1779797410000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-026-11532-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":107,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["11532"],"URL":"https:\/\/doi.org\/10.1007\/s11030-026-11532-3","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"During the preparation of this work, we used Claude 4.5 Sonnet to improve the language in some cases. After using Claude 4.5, we reviewed and edited the content as needed and took full responsibility for the content of the published article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of using generative AI in the manuscript preparation process"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}